Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Incyte Corporation
Incyte Corporation
Incyte Corporation
Institut Bergonié
ModernaTX, Inc.
Hoffmann-La Roche
City of Hope Medical Center
Incyte Corporation
Novartis
Masonic Cancer Center, University of Minnesota
Amgen
University of Minnesota
Barbara Ann Karmanos Cancer Institute
Sandoz
Altor BioScience